Back to results
US 8,715,692 B2Granted
Modified RSV F proteins and methods of their use
AssigneeNovavax, Inc.
InventorsPeter Pushko, Yingyun Wu, Michael Massare, Ye Liu, Gale Smith, Bin Zhou
Life of this patent
Estimating the term…
Abstract
The present invention is generally related to modified or mutated respiratory syncytial virus fusion (F) proteins and methods for making and using them, including immunogenic compositions such as vaccines for the treatment and/or prevention of RSV infection.
Claims19
An RSV F protein comprising the amino acid sequence of SEQ ID NO:
- 8.
An RSV F protein consisting of the amino acid sequence of SEQ ID NO:
- 8.
Dependencies are inferred from the claim text.